TransMedics Group Inc vs Zoetis Inc — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Zoetis Inc is far larger — about 12.6× TransMedics Group Inc's market cap, and Zoetis Inc pays a 2.78% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| TMDX | ZTS | |
|---|---|---|
Market Cap | $2.54B | $31.95B |
Sector | Technology | Health |
52-Week High | $150.42 | $156.76 |
52-Week Low | $61.99 | $71.91 |
Enterprise Value | $2.94B | $39.24B |
Dividend Yield | — | 2.78% |
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →